Racing Medication Testing Consortium

Dr. Michael Hardy has been hired as its next Executive Director of the Racing Medication & Testing Consortium. In his new role, Dr. Hardy will be responsible for the management of the RMTC's Laboratory Accreditation and External Quality Assurance Program in conjunction with the new Horseracing Integrity and Welfare Unit. He will also be charged with the administration of the RMTC's Scientific Advisory Committee process, the monitoring of emerging threats to the integrity of racing and the health and welfare of racehorses, administrative oversight of RMTC-funded research projects, and coordinating...

The Racing Medication & Testing Consortium (RMTC) has announced that it will fund the research proposal, "Detection of Bisphosphonates Using Metabolomics," submitted by Dr. Bethany Keen at the University of Pennsylvania's Equine Testing and Research Laboratory. Dr. Keen's research to date has been conducted in Australia and focused on equine anti-doping, analytical chemistry, and statistics. Metabolomics is an emerging field in doping control and represents a novel testing approach that identifies cellular effects unique to a class of drugs rather than identifying the specific molecule responsible for those effects. "The...

The Racing Medication Testing Consortium (RMTC) and the National Thoroughbred Racing Association (NTRA) Safety & Integrity Alliance have announced that registration is full for the third annual Reg Vet CE Conference scheduled for Mar. 2-3, 2020, at Santa Anita Park. A total of 60 veterinarians representing North America and the Caribbean, Australia, Hong Kong, Great Britain, and Chile will participate in 18 hours of continuing education approved by the Registry of Approved Continuing Education (RACE) program of the American Association of Veterinary State Boards (AAVSB). Lectures, labs, and on-track drills...